Mizuho analyst Vijay Rakesh maintains Broadcom (NASDAQ:AVGO) with a Buy and raises the price target from $520 to $545.
What 6 Analyst Ratings Have To Say About Intercept Pharmaceuticals
Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings within the last quarter: